Residency · Residency · Interventional Radiology
Percutaneous Biopsy: Liver, Kidney, and Soft Tissue
Introduction
Image-guided percutaneous biopsy is a fundamental interventional radiology procedure that provides tissue for histopathological diagnosis while avoiding open surgical exploration. Advances in imaging guidance, needle technology, and tissue processing have made percutaneous biopsy the standard of care for characterizing focal lesions, diagnosing diffuse parenchymal disease, and guiding treatment decisions.
General Principles
Indications
Characterization of focal masses (benign vs. malignant, primary vs. metastatic). Diagnosis of diffuse parenchymal disease (e.g., hepatic fibrosis, renal glomerulonephritis). Molecular profiling and biomarker analysis for targeted therapy. Assessment of transplant organ rejection. Evaluation of infection or inflammatory conditions.
Contraindications
Uncorrectable coagulopathy (INR greater than 1.5, platelets less than 50,000). Lack of safe access path avoiding critical structures. Suspected hemangioma or highly vascular lesion (relative; core biopsy may be acceptable with appropriate technique). Echinococcal cyst (risk of anaphylaxis and peritoneal seeding). Uncooperative patient unable to follow breathing instructions.
Needle Types
| Technique | Gauge | Sample Type | Advantage | Limitation |
|---|---|---|---|---|
| Fine-needle aspiration (FNA) | 20-25 | Cytology | Lower complication rate | No tissue architecture |
| Core needle biopsy (CNB) | 16-20 | Histology (tissue cores) | Architectural/IHC analysis | Higher bleeding risk |
| Coaxial technique | Outer 17-19 | Multiple cores via single puncture | Fewer organ punctures | Slightly larger initial access |
Fine-needle aspiration (FNA): 20-25 gauge; cytologic sampling; lower complication rate. Core needle biopsy (CNB): 16-20 gauge; provides tissue architecture for histology. Coaxial technique: outer introducer needle placed once; multiple core samples obtained through it without repeated organ punctures. Automated spring-loaded devices (e.g., BioPince, Temno) provide consistent tissue cores.
Liver Biopsy
Focal Lesion Biopsy
Imaging guidance: ultrasound preferred for most lesions; CT for lesions not visible on US. Avoid traversing the hepatic capsule multiple times; use coaxial technique. Biopsy viable-appearing periphery of the lesion, avoiding central necrosis. For suspected HCC, core biopsy is preferred over FNA to enable architectural and immunohistochemical analysis.
Diffuse Liver Disease Biopsy
Performed to stage fibrosis/cirrhosis, diagnose steatohepatitis, or assess transplant rejection. Use a subcostal or intercostal approach targeting the right hepatic lobe. Minimum tissue length of 20 mm with 11 or more portal tracts is needed for adequate staging. Transjugular liver biopsy is preferred when ascites, coagulopathy, or morbid obesity precludes the percutaneous approach.
Complications Specific to Liver
Hemorrhage: most significant; 0.5% require intervention; subcapsular hematoma or hemoperitoneum. Bile leak/biloma: rare; more common when biopsying dilated bile ducts. Tumor seeding along the needle tract: rare (less than 1%) with coaxial technique; concern with HCC and cholangiocarcinoma.
Kidney Biopsy
Native Kidney Biopsy
Primary indication: evaluation of medical renal disease (glomerulonephritis, proteinuria, hematuria). Target the lower pole cortex to minimize risk to hilar vessels. Patient positioned prone; real-time ultrasound guidance is standard. Use an 18-gauge automated core needle; typically 2-3 passes for adequate tissue (minimum 10 glomeruli for medical renal disease). Post-biopsy imaging at 1 hour to assess for perinephric hematoma.
Renal Mass Biopsy
Indicated when imaging is indeterminate or when histology would change management. Core biopsy with coaxial technique to reduce tract seeding risk. Diagnostic accuracy exceeds 90% for distinguishing benign from malignant lesions. Complications include hemorrhage (self-limited perinephric hematoma in up to 90% of cases; clinically significant bleeding in less than 1%).
Transplant Kidney Biopsy
Performed for graft dysfunction to differentiate rejection from drug toxicity or recurrent disease. Superficial location in the iliac fossa allows easy US-guided access. Use 18-gauge needle; 2 cores typically sufficient (minimum 7 glomeruli and 1 artery per Banff criteria).
Soft Tissue Biopsy
Musculoskeletal Masses
CT guidance is standard for deep soft tissue and osseous lesions. For suspected sarcoma, plan the biopsy tract so it can be excised at the time of definitive surgery. Consult with orthopedic oncology prior to biopsy to coordinate tract placement. Core biopsy is essential; FNA alone is insufficient for sarcoma subtyping.
Retroperitoneal and Pelvic Masses
CT-guided biopsy with attention to surrounding bowel, vasculature, and ureter. Anterior or posterolateral approaches depending on mass location. Lymphoma diagnosis requires core tissue for flow cytometry and immunohistochemistry.
Lung and Mediastinal Lesions
CT-guided transthoracic needle biopsy for peripheral pulmonary nodules. Pneumothorax rate: 15-25%; chest tube placement required in 5-10%. Risk factors for pneumothorax: small lesion, deep lesion, crossing a fissure, emphysema.
Postprocedural Care
Monitor vital signs for 2-4 hours post-procedure. Liver and kidney biopsies: bed rest with the biopsy side down for 2-4 hours. Instruct patients to avoid heavy lifting and strenuous activity for 48-72 hours. Provide clear discharge instructions including signs of hemorrhage and when to seek care.
Key Clinical Pearls
The coaxial technique reduces the number of organ punctures and minimizes tumor seeding risk; it should be the standard approach for suspected malignancy. For diffuse liver disease, sample length and portal tract count are critical quality metrics; specimens shorter than 20 mm have significantly higher sampling error. Always communicate with the pathologist before the procedure regarding sample handling requirements (e.g., fresh tissue for flow cytometry, electron microscopy fixative for renal biopsies). For suspected sarcoma, coordinate biopsy tract planning with the surgical team to ensure the tract can be included in the resection specimen.
References
- Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined
- Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined
- Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined
- Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined Defined